サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1781946

ヒトマイクロバイオーム市場：製品別、疾患別、タイプ別、投与経路別、エンドユーザー別、国別、地域別-2025～2032年の世界産業分析、市場規模、市場シェア、予測

Human Microbiome Market, By Product, By Diseases, By Type, By Route of Administration, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.46円
ヒトマイクロバイオーム市場：製品別、疾患別、タイプ別、投与経路別、エンドユーザー別、国別、地域別-2025～2032年の世界産業分析、市場規模、市場シェア、予測
出版日: 2025年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートのハイライト

ヒトマイクロバイオーム市場規模は2024年に8億2,190万米ドルとなり、2025～2032年にかけてCAGR 31.20%で拡大

ヒトマイクロバイオーム市場-市場力学

慢性疾患の増加が市場需要を促進

肥満、糖尿病、炎症性腸疾患（IBD）などの慢性疾患の罹患率の増加が、マイクロバイオームベースの治療に対する需要を促進しています。World Obesity Atlas 2023によると、世界人口の38％、約31億2,000万人が過体重または肥満です。また、政府による多額の資金援助がマイクロバイオーム科学の進歩を加速させており、これが世界のヒトマイクロバイオーム市場の成長を後押ししています。しかし、研究開発費の高騰と厳しい規制の枠組みが、予測期間中の市場成長の妨げになる可能性があります。その一方で、個別化ヘルスケアを重視する傾向が強まっていることから、マイクロバイオームベースの診断や、個人の微生物叢プロファイルに合わせた治療にはビジネス機会があります。

ヒトマイクロバイオーム市場-主要な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025～2032年）に約31.20%のCAGRで毎年成長すると予測されています。

製品別では、プロバイオティクスは2024年に最大市場シェアを示すと予測されました。

疾患別では、消化器系が2024年の主要疾患です。

製品タイプ別では、2024年には生きたバイオ治療製品（LBP）が主要タイプとなっています。

地域別では、北米のが2024年に収益を生み出す主要市場です。

ヒトマイクロバイオーム市場-セグメンテーション分析

世界のヒトマイクロバイオーム市場は、製品、疾患、タイプ、投与経路、エンドユーザー、地域に基づいてセグメント化されます。

製品はプレバイオティクス、プロバイオティクス、医薬品、シンバイオティクスの4つに分類されます。プロバイオティクスセグメントは、予測期間中、世界のヒトマイクロバイオーム市場で最大の市場シェアを占めると予測されています。この優位性は、腸の健康、免疫力、総合的な健康に対するプロバイオティクスの利点に対する消費者の意識の高まりに起因しています。

市場は疾患別に消化器疾患、感染症、内分泌と代謝疾患、その他の疾患の4つに分類されます。このうち、消化器系疾患セグメントが市場で最大のシェアを占めると予想されています。この優位性は、過敏性腸症候群（IBS）、炎症性腸疾患（IBD）、セリアック病、胃食道逆流症（GERD）などの消化器疾患の有病率の高さに起因しています。

ヒトマイクロバイオーム市場-地理的洞察

北米の地域は世界のヒトマイクロバイオーム市場で最大のシェアを占めています。この優位性は、確立されたヘルスケアインフラ、マイクロバイオーム調査への多額の投資、慢性疾患の高い有病率に起因します。また、アジア太平洋のは予測期間中、ヒトマイクロバイオーム市場で最も急速な成長を遂げると予測されています。この急拡大の背景には、マイクロバイオームの健康に対する意識の高まり、個別化医療に対する需要の高まり、シーケンス技術の進歩があります。

ヒトマイクロバイオーム市場-競合情勢

個別化医療とマイクロバイオームベースの治療に対する関心の高まりが、この新興セグメントにおける企業間の激しい競争を促進しています。産業各社は研究機関やヘルスケアプロバイダとの戦略的提携に注力し、製品開発を加速させています。その多くは、新規の微生物ベースの診断薬や治療を発見するための研究開発に多額の投資を行っています。さらに、各社はパイプラインを強化するために特許を取得し、ライセンシング契約を結んでいます。未開拓地域への進出や、消費者を対象にしたマイクロバイオーム製品の開発も、主要な競合戦略を形成しています。

目次

第1章 ヒトマイクロバイオーム市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ヒトマイクロバイオームの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ヒトマイクロバイオーム産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 ヒトマイクロバイオーム市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 ヒトマイクロバイオーム市場情勢

  • ヒトマイクロバイオーム市場シェア分析、2024年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ヒトマイクロバイオーム市場-製品別

  • 概要
    • 製品別セグメントシェア分析
    • プロバイオティクス
    • 医薬品
    • シンバイオティクス

第8章 ヒトマイクロバイオーム市場-疾患別

  • 概要
    • 疾患別セグメントシェア分析
    • 消化器疾患
    • 感染症
    • 内分泌と代謝疾患
    • その他

第9章 ヒトマイクロバイオーム市場-タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • バイオ治療製品（LBP）
    • 細菌コンソーシアム移植（BCT）/糞便微生物移植（FMT）
    • その他のマイクロバイオームタイプ

第10章 ヒトマイクロバイオーム市場-投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 直腸
    • 経口

第11章 ヒトマイクロバイオーム市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 長期ケア施設
    • 病院とクリニック
    • その他

第12章 ヒトマイクロバイオーム市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第13章 主要ベンダー分析-ヒトマイクロバイオーム産業

  • 競合ダッシュボード
    • 競合ベンチマーキング
    • 競合ポジショニング
  • 企業プロファイル
    • ENTEROME
    • Pendulum
    • DuPont
    • Yakult USA Inc.
    • Metabiomics
    • Vedanta Biosciences, Inc.
    • OptibIoTix Health plc
    • Microbiome Therapeutics Innovation Group
    • BioHM Health
    • Osel, Inc.
    • Seres Therapeutics
    • Infinant Health Inc.
    • Merck & Co., Inc.
    • Theriva Biologics
    • Qualigen Therapeutics, Inc.
    • Synlogic
    • SymbIoTix, LLC
    • ResbIoTic
    • Symberix, Inc.
    • Exegi Pharma Inc.
    • Seed Health Inc.
    • Biogaia AB
    • BiomeBank
    • Ferring Pharmaceuticals
    • その他

第14章 アナリストの全方位展望

目次
Product Code: ANV5432

REPORT HIGHLIGHT

Human microbiome market size was valued at US$ 821.90 Million in 2024, expanding at a CAGR of 31.20% from 2025 to 2032.

The human microbiome refers to the diverse community of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit various parts of the human body such as the gut, skin, mouth, and respiratory tract. These microorganisms play a vital role in maintaining health by aiding digestion, supporting the immune system, and protecting against pathogens. Disruptions in the microbiome balance are linked to various diseases, including obesity, diabetes, and autoimmune disorders.

Human Microbiome Market- Market Dynamics

Increasing prevalence of chronic diseases to propel market demand

The increasing incidence of chronic conditions such as obesity, diabetes, and inflammatory bowel disease (IBD) is propelling the demand for microbiome-based therapies. According to the World Obesity Atlas 2023, 38% of the global population, approximately 3.12 billion people are overweight or obese. In addition, substantial government funding is accelerating advancements in microbiome science, which is driving the growth of the global human microbiome market. However, high cost of R&D and stringent regulatory frameworks may hamper the market growth during the forecast period. On the contrary, the growing emphasis on personalized healthcare presents opportunities for microbiome-based diagnostics and treatments tailored to individual microbiota profiles.

Human Microbiome Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 31.20% over the forecast period (2025-2032)

Based on Product segmentation, probiotics was predicted to show maximum market share in the year 2024

Based on Diseases segmentation, gastrointestinal was the leading Diseases in 2024

Based on Type segmentation, live biotherapeutic products (LBP) was the leading Type in 2024

On the basis of region, North America was the leading revenue generator in 2024

Human Microbiome Market- Segmentation Analysis:

The Global Human Microbiome Market is segmented on the basis of Product, Diseases, Type, Route of Administration, End-user, and Region.

The market is divided into four categories based on Product: prebiotics, probiotics, drugs, and sybnbiotics. The probiotics segment is anticipated to hold the largest market share in the global human microbiome market during the forecast period. This dominance is attributed to increasing consumer awareness of the benefits of probiotics for gut health, immunity, and overall wellness.

The market is divided into four categories based on Diseases: gastrointestinal diseases, infectious diseases, endocrine & metabolic disorders, and other diseases. Among these, the gastrointestinal diseases segment is anticipated to hold the largest market share in the market. This dominance is attributed to the high prevalence of gastrointestinal conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), celiac disease, and gastroesophageal reflux disease (GERD).

Human Microbiome Market- Geographical Insights

The North America region holds the largest share of the global human microbiome market. This dominance is attributed to a well-established healthcare infrastructure, significant investments in microbiome research, and a high prevalence of chronic diseases. Besides, the Asia-Pacific region is projected to experience the fastest growth in the human microbiome market during the forecast period. This rapid expansion is driven by increasing awareness of microbiome health, rising demand for personalized medicine, and advancements in sequencing technologies.

Human Microbiome Market- Competitive Landscape:

Rising interest in personalized medicine and microbiome-based therapies is driving intense competition among companies in this emerging field. Industry participants are focusing on strategic collaborations with research institutions and healthcare providers to accelerate product development. Many are investing heavily in R&D to discover novel microbiome-based diagnostics and therapeutics. Additionally, companies are securing patents and engaging in licensing agreements to strengthen their pipelines. Expansion into untapped regions and the development of consumer-targeted microbiome products also form key competitive strategies.

Recent Developments:

In February 2025, Seres Therapeutics launched SER-109, the first FDA-approved microbiome therapy in the U.S., designed to treat recurrent C. difficile infection by restoring gut microbiota using live bacterial spores.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN MICROBIOME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • ENTEROME
  • Pendulum
  • DuPont
  • Yakult U.S.A. Inc.
  • Metabiomics
  • Vedanta Biosciences, Inc.
  • Optibiotix Health plc
  • Microbiome Therapeutics Innovation Group
  • BioHM Health
  • Osel, Inc.
  • Seres Therapeutics
  • Infinant Health Inc.
  • Merck & Co., Inc.
  • Theriva Biologics
  • Qualigen Therapeutics, Inc.
  • Synlogic
  • Symbiotix, LLC
  • Resbiotic
  • Symberix, Inc.
  • Exegi Pharma Inc.
  • Seed Health Inc.
  • Biogaia AB
  • BiomeBank
  • Ferring Pharmaceuticals
  • Others

GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Prebiotics
  • Drugs
  • Synbiotics

GLOBAL HUMAN MICROBIOME MARKET, BY DISEASES- MARKET ANALYSIS, 2019 - 2032

  • Gastrointestinal Diseases
  • Infectious Diseases
  • Endocrine & Metabolic Disorders
  • Other Diseases

GLOBAL HUMAN MICROBIOME MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Live Biotherapeutic Products (LBP)
  • Bacterial Consortia Transplantation (BCT) / Fecal Microbiota Transplantation (FMT)
  • Other Microbiome Types

GLOBAL HUMAN MICROBIOME MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Rectal
  • Oral

GLOBAL HUMAN MICROBIOME MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Long-term Care Facilities
  • Hospitals & Clinics
  • Others

GLOBAL HUMAN MICROBIOME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Human Microbiome Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Human Microbiome Market Snippet by Product
    • 2.1.2. Human Microbiome Market Snippet by Diseases
    • 2.1.3. Human Microbiome Market Snippet by Type
    • 2.1.4. Human Microbiome Market Snippet by Route of Administration
    • 2.1.5. Human Microbiome Market Snippet by End User
    • 2.1.6. Human Microbiome Market Snippet by Country
    • 2.1.7. Human Microbiome Market Snippet by Region
  • 2.2. Competitive Insights

3. Human Microbiome Key Market Trends

  • 3.1. Human Microbiome Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Human Microbiome Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Human Microbiome Market Opportunities
  • 3.4. Human Microbiome Market Future Trends

4. Human Microbiome Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Human Microbiome Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Human Microbiome Market Landscape

  • 6.1. Human Microbiome Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Human Microbiome Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Probiotics
    • 7.1.3. Drugs
    • 7.1.4. Synbiotics

8. Human Microbiome Market - By Diseases

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diseases, 2024 & 2032 (%)
    • 8.1.2. Gastrointestinal Diseases
    • 8.1.3. Infectious Diseases
    • 8.1.4. Endocrine & Metabolic Disorders
    • 8.1.5. Other Diseases

9. Human Microbiome Market - By Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 9.1.2. Live Biotherapeutic Products (LBP)
    • 9.1.3. Bacterial Consortia Transplantation (BCT) / Fecal Microbiota Transplantation (FMT)
    • 9.1.4. Other Microbiome Types

10. Human Microbiome Market - By Route of Administration

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 10.1.2. Rectal
    • 10.1.3. Oral

11. Human Microbiome Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Long-term Care Facilities
    • 11.1.3. Hospitals & Clinics
    • 11.1.4. Others

12. Human Microbiome Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Human Microbiome Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Human Microbiome Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Human Microbiome Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Human Microbiome Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Human Microbiome Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Human Microbiome Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. ENTEROME
    • 13.2.2. Pendulum
    • 13.2.3. DuPont
    • 13.2.4. Yakult U.S.A. Inc.
    • 13.2.5. Metabiomics
    • 13.2.6. Vedanta Biosciences, Inc.
    • 13.2.7. Optibiotix Health plc
    • 13.2.8. Microbiome Therapeutics Innovation Group
    • 13.2.9. BioHM Health
    • 13.2.10. Osel, Inc.
    • 13.2.11. Seres Therapeutics
    • 13.2.12. Infinant Health Inc.
    • 13.2.13. Merck & Co., Inc.
    • 13.2.14. Theriva Biologics
    • 13.2.15. Qualigen Therapeutics, Inc.
    • 13.2.16. Synlogic
    • 13.2.17. Symbiotix, LLC
    • 13.2.18. Resbiotic
    • 13.2.19. Symberix, Inc.
    • 13.2.20. Exegi Pharma Inc.
    • 13.2.21. Seed Health Inc.
    • 13.2.22. Biogaia AB
    • 13.2.23. BiomeBank
    • 13.2.24. Ferring Pharmaceuticals
    • 13.2.25. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us